Regenerative Medicine Market in the US 2012-2016

TechNavio's analysts forecast the Regenerative Medicine market in the US to grow at a CAGR of 15.83 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing number of degenerative diseases. The Regenerative Medicine market in the US has also been witnessing an increasing number of mergers and acquisitions. However, stringent regulatory approval processes could pose a challenge to the growth of this market.
TechNavio's report, the Regenerative Medicine Market in the US 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years in the US. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this space include Baxter International Inc., Medtronic Inc., Stryker Corp., and Zimmer Holdings Inc.
The other vendors mentioned in the report are Advanced Cell Technology Inc., Athersys Inc., Arteriocyte Inc., Cytori Therapeutics Inc., CryoLife, Inc., Genzyme Corp., Geron Corp., Integra Life Sciences Holdings Corp., InVivo Therapeutics, Kensey Nash Corp., Kinetic Concepts Inc., NeoStem Inc., Osiris Therapeutics Inc., Osteotech Inc., and RTI Biologics Inc.
Key questions answered in this report:
What will the market size be in 2016 and what will be the growth rate?
What are key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by key vendors?
What are the strengths and weaknesses of each of these key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details provided within the report.

01. Executive Summary
02. List of Abbreviations
03. Introduction
04. Market Research Methodology
Market Research Process
Research Design
Research Methodology
05. Scope of the Report
Market Overview
Product Offerings
06. Market Landscape
06.1 Regenerative Medicine market in the US
Market Size and Forecast
06.2 Market Segmentation Based on Technology
06.3 Market Segmentation Based on Application
06.4 Five Forces Analysis
07. Vendor Landscape
08. Buying Criteria
09. Market Growth Drivers
10. Drivers and their Impact
11. Market Challenges
12. Impact of Drivers and Challenges
13. Market Trends
14. Key Vendor Analysis
14.1 Baxter International Inc.
Business Overview
Key Information
SWOT Analysis
14.2 Medtronic Inc.
Business Overview
Key Information
SWOT Analysis
14.3 Stryker Corp.
Business Overview
Key Information
SWOT Analysis
14.4 Zimmer Holdings Inc.
Business Overview
Key Information
SWOT Analysis
15. Other Reports in this Series

List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Regenerative Medicine Market in the US 2012-2016 (US$ billion)
Exhibit 3: Market Segmentation by Technology
Exhibit 4: Market Segmentation by Technology 2012
Exhibit 5: Regenerative Medicine Market in the US Segmentation by Application
Exhibit 6: Regenerative Medicine Market Segmentation by Application2012
Exhibit 7: Business Segmentation of Baxter International Inc.
Exhibit 8: Business Segmentation of Medtronic Inc.
Exhibit 9: Business Segmentation of Stryker Corp.